Temporal and spatial distribution of Nrf2 in rat brain following stroke: Quantification of nuclear to cytoplasmic Nrf2 content using a novel immunohistochemical technique

Journal of Physiology

Volumn 591, Issue 14, 2013, Pages 3525-3538

  Srivastava, Salil ^a   Alfieri, Alessio ^a   Siow, Richard C M ^a   Mann, Giovanni E ^a   Fraser, Paul A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMINOBENZIDINE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN INFARCTION; BRAIN LEVEL; BRAIN TISSUE; CELL CULTURE; CELL LEVEL; CELL NUCLEUS; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; EX VIVO STUDY; HEMISPHERE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; TIME SERIES ANALYSIS; TRANSCRIPTION INITIATION;

ANIMALS; BRAIN; CELL LINE; CELL NUCLEUS; CYTOPLASM; INFARCTION, MIDDLE CEREBRAL ARTERY; ISOTHIOCYANATES; MALE; MICE; NF-E2-RELATED FACTOR 2; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84880729684     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.257964     Document Type: Article

References (62)

1. Alfieri A, Srivastava S, Siow RC, Modo M, Fraser PA & Mann GE (2011). Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol 589, 4125-4136.
2. Bell KF, Fowler JH, Al-Mubarak B, Horsburgh K & Hardingham GE (2011). Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning. Oxid Med Cell Longev 2011, 689524.
3. Benedict AL, Mountney A, Hurtado A, Bryan KE, Schnaar RL, Dinkova-Kostova AT & Talalay P (2012). Neuroprotective effects of sulforaphane after contusive spinal cord injury. J Neurotrauma 29, 2576-2586.
4. Candelario-Jalil E (2009). Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 10, 644-654.
5. Chapple SJ, Siow RC & Mann GE (2012). Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol 44, 1315-1320.
6. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE & Chan PH (2011). Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14, 1505-1517.
7. Chen HH, Chen YT, Huang YW, Tsai HJ & Kuo CC (2012). 4-Ketopinoresinol, a novel naturally occurring ARE activator, induces the Nrf2/HO-1 axis and protects against oxidative stress-induced cell injury via activation of PI3K/AKT signalling. Free Radic Biol Med 52, 1054-1066.
8. Cheung KL & Kong AN (2010). Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12, 87-97.
9. Dang J, Brandenburg LO, Rosen C, Fragoulis A, Kipp M, Pufe T, Beyer C & Wruck CJ (2012). Nrf2 expression by neurons, astroglia, and microglia in the cerebral cortical penumbra of ischemic rats. J Mol Neurosci 46, 578-584.
10. Danilov CA, Chandrasekaran K, Racz J, Soane L, Zielke C & Fiskum G (2009). Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia 57, 645-656.
11. Dinkova-Kostova AT & Kostov RV (2012). Glucosinolates and isothiocyanates in health and disease. Trends Mol Med 18, 337-347.
12. Dirnagl U, Iadecola C & Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22, 391-397.
13. Dirnagl U, Lindauer U, Them A, Schreiber S, Pfister HW, Koedel U, Reszka R, Freyer D & Villringer A (1995). Global cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivo. J Cereb Blood Flow Metab 15, 929-940.
14. Fraser PA (2011). The role of free radical generation in increasing cerebrovascular permeability. Free Radic Biol Med 51, 967-977.
15. Gauden V, Hu DE, Kurokawa T, Sarker MH & Fraser PA (2007). Novel technique for estimating cerebrovascular permeability demonstrates capsazepine protection following ischemia-reperfusion. Microcirculation 14, 767-778.
16. Graham RC Jr & Karnovsky MJ (1966). The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14, 291-302.
17. Heiss E, Herhaus C, Klimo K, Bartsch H & Gerhauser C (2001). Nuclear factor kB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J Biol Chem 276, 32008-32015.
18. Iadecola C & Anrather J (2011). Stroke research at a crossroad: asking the brain for directions. Nat Neurosci 14, 1363-1368.
19. Ikonomidou C & Kaindl AM (2011). Neuronal death and oxidative stress in the developing brain. Antioxid Redox Signal 14, 1535-1550.
20. Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M & Mann GE (2004). Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res 94, 609-616.
21. Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S & Yamamoto M (2000). Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275, 16023-16029.
22. Itoh K, Mimura J & Yamamoto M (2010). Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid Redox Signal 13, 1665-1678.
23. Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernandez-Ruiz J & Cuadrado A (2011). Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal 14, 2347-2360.
24. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T & Brandes RP (2007). NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38, 3000-3006.
25. Kam KY, Yu SJ, Jeong N, Hong JH, Jalin AM, Lee S, Choi YW, Lee CK & Kang SG (2011). p-Hydroxybenzyl alcohol prevents brain injury and behavioral impairment by activating Nrf2, PDI, and neurotrophic factor genes in a rat model of brain ischemia. Mol Cells 31, 209-215.
26. Kaya M, Kalayci R, Kucuk M, Arican N, Elmas I, Kudat H & Korkut F (2003). Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats. Life Sci 73, 3235-3244.
27. Kirkeby S & Thomsen CE (2005). Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software. J Immunol Methods 301, 102-113.
28. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, Emmert M, Baltzer N, Neundorfer B, Schoffski O & Krobot KJ (2006). Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 37, 1179-1183.
29. Kraft AD, Johnson DA & Johnson JA (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 24, 1101-1112.
30. Kwak MK, Itoh K, Yamamoto M & Kensler TW (2002). Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 22, 2883-2892.
31. Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S & Kong AN (2008). Activation of Nrf2-antioxidant signalling attenuates NFkB-inflammatory response and elicits apoptosis. Biochem Pharmacol 76, 1485-1489.
32. Matkowskyj KA, Schonfeld D & Benya RV (2000). Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software Photoshop and Matlab. J Histochem Cytochem 48, 303-312.
33. Modo M, Stroemer RP, Tang E, Veizovic T, Sowniski P & Hodges H (2000). Neurological sequelae and long-term behavioural assessment of rats with transient middle cerebral artery occlusion. J Neurosci Methods 104, 99-109.
34. Montgomery JD, Hensler HR, Jacobson LP & Jenkins FJ (2008). Validation of a low cost computer-based method for quantification of immunohistochemistry-stained sections. Appl Immunohistochem Mol Morphol 16, 400-404.
35. Motohashi H & Yamamoto M (2004). Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10, 549-557.
36. Nakane PK & Pierce GB Jr (1967). Enzyme-labelled antibodies for the light and electron microscopic localization of tissue antigens. J Cell Biol 33, 307-318.
37. Niture SK, Jain AK, Shelton PM & Jaiswal AK (2011). Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression. J Biol Chem 286, 28821-28832.
38. Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N & Tataroglu C (2007). Oxidative stress in acute ischemic stroke. J Clin Neurosci 14, 1062-1066.
39. Pan H, Wang H, Zhu L, Mao L, Qiao L & Su X (2011). Depletion of Nrf2 enhances inflammation induced by oxyhemoglobin in cultured mice astrocytes. Neurochem Res 36, 2434-2441.
40. Peters O, Back T, Lindauer U, Busch C, Megow D, Dreier J & Dirnagl U (1998). Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 18, 196-205.
41. Rowlands DJ, Chapple S, Siow RC & Mann GE (2011). Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signalling in endothelial cells: roles for F-actin and GPR30. Hypertension 57, 833-840.
42. Shah ZA, Li RC, Ahmad AS, Kensler TW, Yamamoto M, Biswal S & Dore S (2010). The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. J Cereb Blood Flow Metab 30, 1951-1961.
43. Shah ZA, Li RC, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S & Dore S (2007). Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience 147, 53-59.
44. Shen G, Hebbar V, Nair S, Xu C, Li W, Lin W, Keum YS, Han J, Gallo MA & Kong AN (2004). Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J Biol Chem 279, 23052-23060.
45. Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P & Murphy TH (2005). Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 280, 22925-22936.
46. Shohami E, Beit-Yannai E, Horowitz M & Kohen R (1997). Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome. J Cereb Blood Flow Metab 17, 1007-1019.
47. Siow RC & Mann GE (2010). Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis Mol Aspects Med 31, 468-477.
48. Son TG, Camandola S, Arumugam TV, Cutler RG, Telljohann RS, Mughal MR, Moore TA, Luo W, Yu QS, Johnson DA, Johnson JA, Greig NH & Mattson MP (2010). Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia. J Neurochem 112, 1316-1326.
49. Sun Z, Huang Z & Zhang DD (2009). Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS ONE 4, e6588.
50. Taguchi K, Motohashi H & Yamamoto M (2011). Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16, 123-140.
51. Tanaka N, Ikeda Y, Ohta Y, Deguchi K, Tian F, Shang J, Matsuura T & Abe K (2011). Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion. Brain Res 1370, 246-253.
52. Taylor CR & Levenson RM (2006). Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 49, 411-424.
53. Thompson D, Edelsberg J, Colditz GA, Bird AP & Oster G (1999). Lifetime health and economic consequences of obesity. Arch Intern Med 159, 2177-2183.
54. Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Yoshida A, Uchida K, Hiai H, Ochi H & Osawa T (1997). Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76, 365-374.
55. Williamson TP, Johnson DA & Johnson JA (2012). Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity. Neurotoxicology 33, 272-279.
56. Woodfin A, Hu DE, Sarker M, Kurokawa T & Fraser P (2011). Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion. Free Radic Biol Med 50, 518-524.
57. Yamato S, Kobayashi K, Ebara K, Shimada K & Ohta S (2003). High performance liquid chromatographic determination of acetoacetate by post-column derivatization with p-nitrobenzene diazonium fluoroborate. Biol Pharm Bull 26, 397-400.
58. Yang C, Zhang X, Fan H & Liu Y (2009). Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 1282, 133-141.
59. Zhang Y, Talalay P, Cho CG & Posner GH (1992). A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89, 2399-2403.
60. Zhao J, Kobori N, Aronowski J & Dash PK (2006). Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett 393, 108-112.
61. Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, Grotta JC & Aronowski J (2007). Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke 38, 3280-3286.
62. Zipper LM & Mulcahy RT (2003). Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol Sci 73, 124-134.